Item 7.01 Regulation FD Disclosure.

Included as Exhibit 99.1 to this Current Report on Form 8-K is a presentation titled "Atopic Dermatitis Overview," dated October 2020, which is incorporated herein by reference. We intend to utilize this presentation and its contents in various meetings with securities analysts, investors and others, beginning on October 26, 2020.

The information in this Current Report on Form 8-K, including Exhibit 99.1, shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act") or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such a filing.

Item 9.01 Financial Statements and Exhibits. (d) Exhibits.





Exhibit
  No.     Description
 99.1       Presentation titled "Atopic Dermatitis Overview," dated October 2020
  104     Cover Page Interactive Data File (embedded within the Inline XBRL document)

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses